DyNAbind
Latest round
- Seed
Last raised
- May 2019
Total raised
- Undisclosed
Investors
- 3
About DyNAbind
Founded in 2017 in Dresden, Germany, DyNAbind GmbH focuses on advancing drug discovery by providing DNA-Encoded Library technologies.DyNAbind specializes in the development of advanced DNA-Encoded Library (DEL) technologies designed to streamline and enhance drug discovery processes. Their core offerings include patented tools and high-quality libraries that significantly expand chemical space coverage and improve the reliability of hit identification. One of their standout innovations is a novel DNA architecture that generates new structures to create stronger binders, complemented by a dual-DNA presentation system that markedly improves signal-to-noise ratios by over 30-fold. The company also features a proprietary path-coding system that enhances the informatics pipeline, effectively reducing false positives and negatives in hit identification by increasing usable sequences by over 37%.70. The company's revenue model is structured around partnerships and collaborations with pharmaceutical and biotechnology firms, where clients engage with DyNAbind to utilize its innovative DEL technologies and tools. Transactions typically involve contractual agreements for access to high-quality libraries and informatics solutions, allowing clients to validate compounds and streamline their drug discovery processes. Specific markets targeted for expansion include North America and Asia, with plans to launch new DEL technologies intended to optimize drug discovery by the end of 2024.
Who invested in DyNAbind
3 investors across 1 round
See all investors in DyNAbind
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 8, 2019
Amount
Undisclosed
Investors
Questions about DyNAbind
Who invested in DyNAbind?
DyNAbind has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DyNAbind raised?
DyNAbind has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DyNAbind last raise money?
DyNAbind's most recent round on record is a Seed, in May 2019.
What does DyNAbind do?
Founded in 2017 in Dresden, Germany, DyNAbind GmbH focuses on advancing drug discovery by providing DNA-Encoded Library technologies.
Where is DyNAbind headquartered?
DyNAbind is headquartered in Dresden, Germany.
Which VCs invest in companies like DyNAbind?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at DyNAbind's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like DyNAbind? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.